4-DAY CE Conference - SAN ANTONIO, TX - October 23-26, 2025

1,197
Package Price 899.00

Enhance your expertise with this dynamic 4-day, knowledge-building program. Plus, you’ll be able to apply everything you learn immediately in your practice.                   
 

Conference Dates: October 23-26, 2025 


Location:  San Antonio Marriott Rivercenter on the River Walk     
101 Bowie Street     
San Antonio, TX 78205-3901         
            
Discounted Hotel Sleeping Room Booking click here        

 

4-Day CE Conference Includes:   

 

Days 1:  Dermatology for Primary Care                              
Schedule: 8 AM – 4 PM (includes breaks)                                            
Contact Hours: 6 (0 Rx)                                         
Presenter: Dr. Margaret Bobonich

This Live Dermatology CE program concentrates on the the diagnosis and therapeutic management of skin diseases'. The goal is to enhance your ability to synthesize and integrate new knowledge to formulate management approaches for patient care.     
 

Topics covered:

  • Bacterial infections 
  • Viral infections 
  • Updates in Adnexal/Acneiform disorders 
  • Common Pigmentary Conditions

 

Days 2:  8-hour DEA Registration and Controlled Substance Prescribing                                  
Schedule: 8 AM – 5:30 PM (includes breaks)                                            
Contact Hours: 8 (0 Rx)                                         
Presenter: Dr. Sally Miller

This 8-hour program meets the requirements of the Consolidated Appropriations Act, 2023, which requires that effective June 27, 2023 all prescribers of controlled substances must have a minimum of 8 hours of continuing education in the assessment and management of opioid or other substance use disorder in order to apply for or renew DEA registration. The program includes principles of pain management, opioid prescribing, opioid risk assessment, legislative issues, and management of opioid-use disorder with medically assisted therapy. Additionally, the program presents non-opioid controlled substance considerations, including psychostimulants, benzodiazepines, appetite suppressants, and sedative hypnotics. Indications, selection, and both assessment and management of use disorders is presented. Successful completion of this program complies with eligibility requirements for initial and renewal DEA registration, and meets most state-mandated requirements for opioid prescribing.      

Objectives: 

  • Describe the key steps in pain reception and perception. 
  • Compare and contrast mechanisms of opiate and non-opiate pain agents.
  • Discuss CDC recommendations and legislative considerations in opioid prescribing.
  • Analyze elements of opioid risk assessment.
  • Evaluate indications for and elements of medically assisted therapy.
  • Analyze indications for benzodiazepine therapy and strategies to minimize abuse potential.
  • Evaluate mechanisms and abuse potential of psychostimulants.
  • Compare and contrast controlled and non-controlled options for insomnia.

 

Days 3 & 4:  Pharmacology Update                                   
Schedule: 8 AM – 4 PM (includes breaks)                                            
Contact Hours: 12 (12 Rx)                                         
Presenter: Dr. Margaret Fitzgerald

Dr. Fitzgerald presents recent pharmacology updates that you can immediately implement in your practice. Get the latest guidance on myriad important topics for your practice! 

  • Coming soon

 

Note:  To receive a certificate of completion, each course requires attendance.